Xbrane Biopharma
Xbrane Biopharma: US commercialization partner announced (Redeye)
2024-05-10 11:25
Redeye leave its comments on Xbrane following the announcement of a USD45m deal plus royalties for Xbrane's ranibizumab biosimilar on the US market.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se